Less than 1 min.Read

Q’Apel: Medical Raises $22M in Funding

February 14, 2021

Q’Apel Medical, Inc., a Fremont, Calif.-based neurovascular company, raised $22M in Series C funding
The round included River Cities Capital, Soleus Capital, and incumbent investor Research Corporation Technologies (RCT)
Scott Huennekens, former Chairman, CEO and President of Verb Surgical, and Carter McNabb, Managing Director, River Cities Capital, will join the Board of Directors
Walrus BGC specifically designed to assist doctors in performing mechanical thrombectomy procedures on stroke patients
The Wahoo Control™ Catheter a dual-mode hybrid access system, providing two distinct operational modes – Tracking Mode and Support Mode
In 2021, Q’Apel plans to significantly increase its manufacturing capacity, add additional head count and expand their product portfolio